SB404
Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.
Status:
In House
Latest Action:
Feb. 4, 2026
House: Referred to Committee on Appropriations
Chief Patron:
Louise Lucas (D)
Session:
2026 Regular Session
Summary
As Introduced. Active Pharmaceutical Ingredient Manufacturing Grant Fund.
Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in ... (More) the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is a recommendation of the MEI Project Approval Commission. (Less)-
Bill History
- 01/13/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26102909D
- 01/13/2026 - Senate: Referred to Committee on Finance and Appropriations
- 01/23/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB404)
- 01/27/2026 - Senate: Reported from Finance and Appropriations (14-Y 0-N)
- 01/28/2026 - Senate: Rules suspended
- 01/28/2026 - Senate: Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 01/28/2026 - Senate: Passed by for the day Block Vote (Voice Vote)
- 01/29/2026 - Senate: Read second time
- 01/29/2026 - Senate: Engrossed by Senate (Voice Vote)
- 01/30/2026 - Senate: Read third time and passed Senate (38-Y 0-N 0-A)
- 02/04/2026 - House: Placed on Calendar
- 02/04/2026 - House: Read first time
- 02/04/2026 - House: Referred to Committee on Appropriations
